Login / Signup

Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect.

Yoko NishigaAlexandros P DrainasMaya BaronDebadrita BhattacharyaAmira A BarkalYasaman AhrariRebecca MancusiJason B RossNobuyuki TakahashiAnish ThomasMaximillian DiehnIrving L WeissmanEdward E GravesJulien Sage
Published in: Nature cancer (2022)
Radiation therapy is a mainstay of cancer treatment but does not always lead to complete tumor regression. Here we combine radiotherapy with blockade of the 'don't-eat-me' cell-surface molecule CD47 in small cell lung cancer (SCLC), a highly metastatic form of lung cancer. CD47 blockade potently enhances the local antitumor effects of radiotherapy in preclinical models of SCLC. Notably, CD47 blockade also stimulates off-target 'abscopal' effects inhibiting non-irradiated SCLC tumors in mice receiving radiation. These abscopal effects are independent of T cells but require macrophages that migrate into non-irradiated tumor sites in response to inflammatory signals produced by radiation and are locally activated by CD47 blockade to phagocytose cancer cells. Similar abscopal antitumor effects were observed in other cancer models treated with radiation and CD47 blockade. The systemic activation of antitumor macrophages following radiotherapy and CD47 blockade may be particularly important in patients with cancer who suffer from metastatic disease.
Keyphrases